This inventor holds 31 USPTO granted patents and 4 published patent applications and 10 EPO patents, primarily in Drug Delivery Systems. Top assignees: Biosensors International Group, Ltd., Sendx Medical, Inc., Ppg Industries, Inc.. Active years: 1993-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2002)
- Del Mar, CA (US) (1993 - 2019)
Company Filing History:
13 out of 59 
10 out of 15 
6 out of 2,825 
Years Active: 1993-2019
Areas of Expertise:
Title: **Douglas R Savage: Innovator in Drug Delivery Technologies**
Introduction
Douglas R Savage, based in Del Mar, California, is a trailblazing inventor with an impressive portfolio of 31 patents to his name. His contributions to the field of medical devices, particularly in drug delivery systems, have significantly impacted patient care and treatment methodologies.
Latest Patents
Among his latest innovations is the "Drug delivery endovascular stent and method of use." This patent describes an advancement in drug-eluting stents. The invention focuses on roughening the surface of a metal stent to achieve a surface roughness of at least 20 μin (0.5 μm) and a range of 300-700 μin (7.5-17.5 μm). The unique feature of this stent is its polymer-free coating with a limus drug, applied at a thickness surpassing the roughness of the stent surface. This advancement aims to enhance the effectiveness of drug delivery in vascular applications.
Career Highlights
Throughout his career, Douglas R Savage has worked with notable companies such as Biosensors International Group, Ltd. and Sendx Medical, Inc. His role in these organizations has allowed him to apply his innovative ideas and solidify his reputation in the biomedical field.
Collaborations
Savage has collaborated with esteemed colleagues, including Ronald E Betts and John E Shulze, to further advance the technology underlying medical devices. Their teamwork has contributed to the development of cutting-edge solutions that address critical healthcare needs.
Conclusion
Douglas R Savage continues to be a prominent figure in medical innovation. His groundbreaking patents, particularly in drug delivery systems, underline his commitment to improving healthcare outcomes. As he progresses in his career, his contributions promise to remain influential in the ongoing evolution of medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile